Can infliximab serve as a new therapy for neuropsychiatric symptoms?
Rahmati-Dehkordi F, Birang N, Jalalian MN, Tamtaji Z, Dadgostar E, Aschner M, Shafiee Ardestani M, Jafarpour H, Mirzaei H, Nabavizadeh F, Tamtaji OR.
Rahmati-Dehkordi F, et al. Among authors: aschner m.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 3. doi: 10.1007/s00210-024-03397-w. Online ahead of print.
Naunyn Schmiedebergs Arch Pharmacol. 2024.
PMID: 39225829
Review.